Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, Cardiovascular Treatment, Orthopedic Treatment, Neurological Treatment, Cancer Treatment, Fertility Treatment, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2027
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to 2027.
Medical tourism can be defined as an organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers’ home country. Medical tourists travel across international borders for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. Medical tourists travel to receive medical treatments such as dental treatment, neurological treatment, and cardiovascular treatment.
The growth of the global medical tourism market is majorly driven by affordability and accessibility of quality healthcare services along with assistance from tourism departments and local governments. In addition, availability of latest medical technologies in medical tourism hubs across the globe is expected to fuel the market growth. However, lengthy, partial reimbursement by payers and difficulties associated with travel, language barriers, availability of documentation, and VISA approval issues act as key restraints of the global market. Conversely, wider hospital network under insurance coverage for cashless transactions is expected to serve as a remunerative opportunity for the expansion of the global medical tourism market during the period.
The report segments the market into treatment type and region. On the basis of treatment type, the market is segregated into dental treatment, cosmetic treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and others. Region wise, the medical tourism market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The report provides extensive competitive analysis and profiles of key market players such as Aditya Birla Memorial Hospital, Apollo Hospitals Enterprise Limited, Asian Heart Institute, Barbados Fertility Center, Fortis Healthcare Limited, KPJ Healthcare Berhad, NTT Medical Center Tokyo, Prince Court Medical Centre, Samitivej PCL, Seoul National University Hospital, and Wooridul Spine Hospital.
KEY BENEFITS FOR STAKEHOLDERS
The global medical tourism market is highly competitive, and prominent players have adopted various strategies to garner maximum share. Major players operating in the market include Aditya Birla Memorial Hospital, Apollo Hospitals Enterprise Limited, Asian Heart Institute, Barbados Fertility Center, Fortis Healthcare Limited, KPJ Healthcare Berhad, NTT Medical Center Tokyo, Prince Court Medical Centre, Samitivej PCL, Seoul National University Hospital, and Wooridul Spine Hospital.
Medical tourism can be defined as an organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers’ home country. Medical tourists travel across international borders for the maintenance, enhancement, or restoration of their health through affordable healthcare facilities & treatments available in other countries, which are comparatively expensive in their own country. Medical tourists travel to receive medical treatments such as dental treatment, neurological treatment, and cardiovascular treatment.
The growth of the global medical tourism market is majorly driven by affordability and accessibility of quality healthcare services along with assistance from tourism departments and local governments. In addition, availability of latest medical technologies in medical tourism hubs across the globe is expected to fuel the market growth. However, lengthy, partial reimbursement by payers and difficulties associated with travel, language barriers, availability of documentation, and VISA approval issues act as key restraints of the global market. Conversely, wider hospital network under insurance coverage for cashless transactions is expected to serve as a remunerative opportunity for the expansion of the global medical tourism market during the period.
The report segments the market into treatment type and region. On the basis of treatment type, the market is segregated into dental treatment, cosmetic treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, cancer treatment, fertility treatment, and others. Region wise, the medical tourism market is studied across North America, Europe, Asia-Pacific, and LAMEA.
The report provides extensive competitive analysis and profiles of key market players such as Aditya Birla Memorial Hospital, Apollo Hospitals Enterprise Limited, Asian Heart Institute, Barbados Fertility Center, Fortis Healthcare Limited, KPJ Healthcare Berhad, NTT Medical Center Tokyo, Prince Court Medical Centre, Samitivej PCL, Seoul National University Hospital, and Wooridul Spine Hospital.
KEY BENEFITS FOR STAKEHOLDERS
- This report entails a detailed quantitative analysis of the current market trends from 2019 to 2027 to identify the prevailing opportunities.
- Medical tourism market size and estimations are based on comprehensive analysis of the key developments in the industry.
- In-depth analysis based on region assists to understand the regional market and the strategic business planning.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
- By Treatment Type
- Dental Treatment
- Cosmetic Treatment
- Cardiovascular Treatment
- Orthopedic Treatment
- Neurological Treatment
- Cancer Treatment
- Fertility Treatment
- Other Treatments
- By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- India
- China
- Indonesia
- Singapore
- Malaysia
- Thailand
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Venezuela
- Costa Rica
- UAE
- South Africa
- Rest of LAMEA
- Aditya Birla Memorial Hospital
- Apollo Hospitals Enterprise Limited
- Asian Heart Institute
- Barbados Fertility Center
- Fortis Healthcare Limited
- KPJ Healthcare Berhad
- NTT Medical Center Tokyo
- Prince Court Medical Centre
- Samitivej PCL
- Seoul National University Hospital
- Wooridul Spine Hospital
- Max Healthcare
- Mount Elizabeth Hospitals
- Narayana Health
The global medical tourism market is highly competitive, and prominent players have adopted various strategies to garner maximum share. Major players operating in the market include Aditya Birla Memorial Hospital, Apollo Hospitals Enterprise Limited, Asian Heart Institute, Barbados Fertility Center, Fortis Healthcare Limited, KPJ Healthcare Berhad, NTT Medical Center Tokyo, Prince Court Medical Centre, Samitivej PCL, Seoul National University Hospital, and Wooridul Spine Hospital.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Reimbursement scenario
3.3.1.Developed regions
3.3.2.Developing regions
3.4.Government regulations
3.5.Top player positioning, 2019
3.6.Porters five forces analysis
3.7.Market dynamics
3.7.1.Drivers
3.7.1.1.Affordable good quality care
3.7.1.2.Availability of quality care
3.7.1.3.Accessible information and care
3.7.1.4.Assistance and support from government agencies and associations
3.7.2.Restraints
3.7.2.1.Limited coverage and lengthy partial reimbursement by payers
3.7.2.2.Difficulties associated with travel, language barriers, availability, documentation, and VISA approval issues
3.7.3.Opportunities
3.7.3.1.Overseas promotional offices are a key source of medical tourists
3.7.3.2.Wider hospital network under insurance coverage for cashless transactions
3.7.4.Impact analyses
3.8.Impact analysis of COVID-19 on the medical tourism market
CHAPTER 4:MEDICAL TOURISM MARKET, BY TREATMENT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Dental Treatment
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.2.1.Market size and forecast, by North America
4.2.2.2.Market size and forecast, by Europe
4.2.2.3.Market size and forecast, by Asia-Pacific
4.2.2.4.Market size and forecast, by LAMEA
4.3.Cosmetic Treatment
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.2.1.Market size and forecast, by North America
4.3.2.2.Market size and forecast, by Europe
4.3.2.3.Market size and forecast, by Asia-Pacific
4.3.2.4.Market size and forecast, by LAMEA
4.4.Cardiovascular treatment
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.2.1.Market size and forecast, by North America
4.4.2.2.Market size and forecast, by Europe
4.4.2.3.Market size and forecast, by Asia-Pacific
4.4.2.4.Market size and forecast, by LAMEA
4.5.Orthopedic treatment
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.2.1.Market size and forecast, by North America
4.5.2.2.Market size and forecast, by Europe
4.5.2.3.Market size and forecast, by Asia-Pacific
4.5.2.4.Market size and forecast, by LAMEA
4.6.Neurological treatment
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.2.1.Market size and forecast, by North America
4.6.2.2.Market size and forecast, by Europe
4.6.2.3.Market size and forecast, by Asia-Pacific
4.6.2.4.Market size and forecast, by LAMEA
4.7.Cancer treatment
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.2.1.Market size and forecast, by North America
4.7.2.2.Market size and forecast, by Europe
4.7.2.3.Market size and forecast, by Asia-Pacific
4.7.2.4.Market size and forecast, by LAMEA
4.8.Fertility treatment
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.8.2.1.Market size and forecast, by North America
4.8.2.2.Market size and forecast, by Europe
4.8.2.3.Market size and forecast, by Asia-Pacific
4.8.2.4.Market size and forecast, by LAMEA
4.9.Other treatments
4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast, by region
4.9.2.1.Market size and forecast, by North America
4.9.2.2.Market size and forecast, by Europe
4.9.2.3.Market size and forecast, by Asia-Pacific
4.9.2.4.Market size and forecast, by LAMEA
CHAPTER 5:MEDICAL TOURISM MARKET, BY REGION
5.1.Overview
5.1.1.Market size and forecast
5.2.North America
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country
5.2.3.Market size and forecast, by treatment type
5.2.3.1.U.S. market size and forecast
5.2.3.1.1.U.S. Medical Tourism MARKET, 2019–2027 ($million)
5.2.3.1.2.Market size and forecast, by treatment type
5.2.3.2.Canada market size and forecast
5.2.3.2.1.Market size and forecast, by treatment type
5.2.3.3.Mexico market size and forecast
5.2.3.3.1.Market size and forecast, by treatment type
5.3.Europe
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country
5.3.3.Market size and forecast, by treatment type
5.3.3.1.Germany market size and forecast
5.3.3.1.1.Market size and forecast, by treatment type
5.3.3.2.France market size and forecast
5.3.3.2.1.Market size and forecast, by treatment type
5.3.3.3.UK market size and forecast
5.3.3.3.1.Market size and forecast, by treatment type
5.3.3.4.Italy market size and forecast
5.3.3.4.1.Market size and forecast, by treatment type
5.3.3.5.Spain market size and forecast
5.3.3.5.1.Market size and forecast, by treatment type
5.3.3.6.Rest of Europe market size and forecast
5.3.3.6.1.Market size and forecast, by treatment type
5.4.Asia-Pacific
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country
5.4.3.Market size and forecast, by treatment type
5.4.3.1.India market size and forecast
5.4.3.1.1.Market size and forecast, by treatment type
5.4.3.2.China market size and forecast
5.4.3.2.1.Market size and forecast, by treatment type
5.4.3.3.Indonesia market size and forecast
5.4.3.3.1.Market size and forecast, by treatment type
5.4.3.4.Singapore market size and forecast
5.4.3.4.1.Market size and forecast, by treatment type
5.4.3.5.Malaysia market size and forecast
5.4.3.5.1.Market size and forecast, by treatment type
5.4.3.6.Thailand market size and forecast
5.4.3.6.1.Market size and forecast, by treatment type
5.4.3.7.South Korea market size and forecast
5.4.3.7.1.Market size and forecast, by treatment type
5.4.3.8.Taiwan market size and forecast
5.4.3.8.1.Market size and forecast, by treatment type
5.4.3.9.Rest of Asia-Pacific market size and forecast
5.4.3.9.1.Market size and forecast, by treatment type
5.5.LAMEA
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country
5.5.3.Market size and forecast, by treatment type
5.5.3.1.Brazil market size and forecast
5.5.3.1.1.Market size and forecast, by treatment type
5.5.3.2.Venezuela market size and forecast
5.5.3.2.1.Market size and forecast, by treatment type
5.5.3.3.Costa Rica market size and forecast
5.5.3.3.1.Market size and forecast, by treatment type
5.5.3.4.UAE market size and forecast
5.5.3.4.1.Market size and forecast, by treatment type
5.5.3.5.South Africa market size and forecast
5.5.3.5.1.Market size and forecast, by treatment type
5.5.3.6.Rest of LAMEA market size and forecast
5.5.3.6.1.Market size and forecast, by treatment type
CHAPTER 6:COMPANY PROFILE
6.1.APOLLO HOSPITALS ENTERPRISE LIMITED
6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.1.6.Key strategic moves and developments
6.2.FORTIS HEALTHCARE LIMITED
6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.3.ASIAN HEART INSTITUTE
6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.4.KPJ HEALTHCARE BERHAD
6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Business performance
6.5.NTT Medical Center Tokyo
6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.6.SEOUL NATIONAL UNIVERSITY HOSPITAL.
6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio
6.7.UZ LEUVEN
6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.8.WOORIDUL SPINE HOSPITAL
6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Product Portfolio
6.9.ADITYA BIRLA MEMORIAL HOSPITAL
6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.10.BARBADOS FERTILITY CENTER
6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio
6.11.PRINCE COURT MEDICAL CENTRE
6.11.1.Company overview
6.11.2.Company snapshot
6.11.3.Operating business segments
6.11.4.Product portfolio
6.12.SAMITIVEJ PCL.
6.12.1.Company overview
6.12.2.Company snapshot
6.12.3.Operating business segments
6.12.4.Product portfolio
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Reimbursement scenario
3.3.1.Developed regions
3.3.2.Developing regions
3.4.Government regulations
3.5.Top player positioning, 2019
3.6.Porters five forces analysis
3.7.Market dynamics
3.7.1.Drivers
3.7.1.1.Affordable good quality care
3.7.1.2.Availability of quality care
3.7.1.3.Accessible information and care
3.7.1.4.Assistance and support from government agencies and associations
3.7.2.Restraints
3.7.2.1.Limited coverage and lengthy partial reimbursement by payers
3.7.2.2.Difficulties associated with travel, language barriers, availability, documentation, and VISA approval issues
3.7.3.Opportunities
3.7.3.1.Overseas promotional offices are a key source of medical tourists
3.7.3.2.Wider hospital network under insurance coverage for cashless transactions
3.7.4.Impact analyses
3.8.Impact analysis of COVID-19 on the medical tourism market
CHAPTER 4:MEDICAL TOURISM MARKET, BY TREATMENT TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Dental Treatment
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.2.1.Market size and forecast, by North America
4.2.2.2.Market size and forecast, by Europe
4.2.2.3.Market size and forecast, by Asia-Pacific
4.2.2.4.Market size and forecast, by LAMEA
4.3.Cosmetic Treatment
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.2.1.Market size and forecast, by North America
4.3.2.2.Market size and forecast, by Europe
4.3.2.3.Market size and forecast, by Asia-Pacific
4.3.2.4.Market size and forecast, by LAMEA
4.4.Cardiovascular treatment
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.2.1.Market size and forecast, by North America
4.4.2.2.Market size and forecast, by Europe
4.4.2.3.Market size and forecast, by Asia-Pacific
4.4.2.4.Market size and forecast, by LAMEA
4.5.Orthopedic treatment
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.2.1.Market size and forecast, by North America
4.5.2.2.Market size and forecast, by Europe
4.5.2.3.Market size and forecast, by Asia-Pacific
4.5.2.4.Market size and forecast, by LAMEA
4.6.Neurological treatment
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.2.1.Market size and forecast, by North America
4.6.2.2.Market size and forecast, by Europe
4.6.2.3.Market size and forecast, by Asia-Pacific
4.6.2.4.Market size and forecast, by LAMEA
4.7.Cancer treatment
4.7.1.Key market trends, growth factors, and opportunities
4.7.2.Market size and forecast, by region
4.7.2.1.Market size and forecast, by North America
4.7.2.2.Market size and forecast, by Europe
4.7.2.3.Market size and forecast, by Asia-Pacific
4.7.2.4.Market size and forecast, by LAMEA
4.8.Fertility treatment
4.8.1.Key market trends, growth factors, and opportunities
4.8.2.Market size and forecast, by region
4.8.2.1.Market size and forecast, by North America
4.8.2.2.Market size and forecast, by Europe
4.8.2.3.Market size and forecast, by Asia-Pacific
4.8.2.4.Market size and forecast, by LAMEA
4.9.Other treatments
4.9.1.Key market trends, growth factors, and opportunities
4.9.2.Market size and forecast, by region
4.9.2.1.Market size and forecast, by North America
4.9.2.2.Market size and forecast, by Europe
4.9.2.3.Market size and forecast, by Asia-Pacific
4.9.2.4.Market size and forecast, by LAMEA
CHAPTER 5:MEDICAL TOURISM MARKET, BY REGION
5.1.Overview
5.1.1.Market size and forecast
5.2.North America
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by country
5.2.3.Market size and forecast, by treatment type
5.2.3.1.U.S. market size and forecast
5.2.3.1.1.U.S. Medical Tourism MARKET, 2019–2027 ($million)
5.2.3.1.2.Market size and forecast, by treatment type
5.2.3.2.Canada market size and forecast
5.2.3.2.1.Market size and forecast, by treatment type
5.2.3.3.Mexico market size and forecast
5.2.3.3.1.Market size and forecast, by treatment type
5.3.Europe
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by country
5.3.3.Market size and forecast, by treatment type
5.3.3.1.Germany market size and forecast
5.3.3.1.1.Market size and forecast, by treatment type
5.3.3.2.France market size and forecast
5.3.3.2.1.Market size and forecast, by treatment type
5.3.3.3.UK market size and forecast
5.3.3.3.1.Market size and forecast, by treatment type
5.3.3.4.Italy market size and forecast
5.3.3.4.1.Market size and forecast, by treatment type
5.3.3.5.Spain market size and forecast
5.3.3.5.1.Market size and forecast, by treatment type
5.3.3.6.Rest of Europe market size and forecast
5.3.3.6.1.Market size and forecast, by treatment type
5.4.Asia-Pacific
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by country
5.4.3.Market size and forecast, by treatment type
5.4.3.1.India market size and forecast
5.4.3.1.1.Market size and forecast, by treatment type
5.4.3.2.China market size and forecast
5.4.3.2.1.Market size and forecast, by treatment type
5.4.3.3.Indonesia market size and forecast
5.4.3.3.1.Market size and forecast, by treatment type
5.4.3.4.Singapore market size and forecast
5.4.3.4.1.Market size and forecast, by treatment type
5.4.3.5.Malaysia market size and forecast
5.4.3.5.1.Market size and forecast, by treatment type
5.4.3.6.Thailand market size and forecast
5.4.3.6.1.Market size and forecast, by treatment type
5.4.3.7.South Korea market size and forecast
5.4.3.7.1.Market size and forecast, by treatment type
5.4.3.8.Taiwan market size and forecast
5.4.3.8.1.Market size and forecast, by treatment type
5.4.3.9.Rest of Asia-Pacific market size and forecast
5.4.3.9.1.Market size and forecast, by treatment type
5.5.LAMEA
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by country
5.5.3.Market size and forecast, by treatment type
5.5.3.1.Brazil market size and forecast
5.5.3.1.1.Market size and forecast, by treatment type
5.5.3.2.Venezuela market size and forecast
5.5.3.2.1.Market size and forecast, by treatment type
5.5.3.3.Costa Rica market size and forecast
5.5.3.3.1.Market size and forecast, by treatment type
5.5.3.4.UAE market size and forecast
5.5.3.4.1.Market size and forecast, by treatment type
5.5.3.5.South Africa market size and forecast
5.5.3.5.1.Market size and forecast, by treatment type
5.5.3.6.Rest of LAMEA market size and forecast
5.5.3.6.1.Market size and forecast, by treatment type
CHAPTER 6:COMPANY PROFILE
6.1.APOLLO HOSPITALS ENTERPRISE LIMITED
6.1.1.Company overview
6.1.2.Company snapshot
6.1.3.Operating business segments
6.1.4.Product portfolio
6.1.5.Business performance
6.1.6.Key strategic moves and developments
6.2.FORTIS HEALTHCARE LIMITED
6.2.1.Company overview
6.2.2.Company snapshot
6.2.3.Operating business segments
6.2.4.Product portfolio
6.2.5.Business performance
6.3.ASIAN HEART INSTITUTE
6.3.1.Company overview
6.3.2.Company snapshot
6.3.3.Operating business segments
6.3.4.Product portfolio
6.4.KPJ HEALTHCARE BERHAD
6.4.1.Company overview
6.4.2.Company snapshot
6.4.3.Operating business segments
6.4.4.Product portfolio
6.4.5.Business performance
6.5.NTT Medical Center Tokyo
6.5.1.Company overview
6.5.2.Company snapshot
6.5.3.Operating business segments
6.6.SEOUL NATIONAL UNIVERSITY HOSPITAL.
6.6.1.Company overview
6.6.2.Company snapshot
6.6.3.Operating business segments
6.6.4.Product portfolio
6.7.UZ LEUVEN
6.7.1.Company overview
6.7.2.Company snapshot
6.7.3.Operating business segments
6.7.4.Product portfolio
6.8.WOORIDUL SPINE HOSPITAL
6.8.1.Company overview
6.8.2.Company snapshot
6.8.3.Product Portfolio
6.9.ADITYA BIRLA MEMORIAL HOSPITAL
6.9.1.Company overview
6.9.2.Company snapshot
6.9.3.Operating business segments
6.9.4.Product portfolio
6.10.BARBADOS FERTILITY CENTER
6.10.1.Company overview
6.10.2.Company snapshot
6.10.3.Operating business segments
6.10.4.Product portfolio
6.11.PRINCE COURT MEDICAL CENTRE
6.11.1.Company overview
6.11.2.Company snapshot
6.11.3.Operating business segments
6.11.4.Product portfolio
6.12.SAMITIVEJ PCL.
6.12.1.Company overview
6.12.2.Company snapshot
6.12.3.Operating business segments
6.12.4.Product portfolio
LIST OF TABLES
TABLE 01.LIST OF MEDICAL TOURISM SPECIALTIES BY COUNTRIES
TABLE 02.GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2019–2027 ($MILLION)
TABLE 03.GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 04.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 05.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 06.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 07.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 08.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 09.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 10.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 11.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 12.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 13.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 14.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 15.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 16.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 17.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 18.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 19.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 20.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 21.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 22.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 23.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 24.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 25.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 26.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 27.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 28.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 29.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 30.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 31.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 32.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 33.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 34.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 35.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 36.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 37.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 38.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 39.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 40.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 41.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 42.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 43.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 44.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 45.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 46.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 47.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 48.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 49.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 50.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 51.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 52.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 53.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 54.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 55.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 56.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 57.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 58.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 59.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 60.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 61.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 62.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 63.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 64.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 65.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 66.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 67.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 68.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 69.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 70.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 71.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 72.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 73.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 74.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 75.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 76.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 77.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 78.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY EUROPE, 2019–2027 ($MILLION)
TABLE 79.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 80.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 81.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 82.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY LAMEA, 2019–2027 ($MILLION)
TABLE 83.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 84.MEDICAL TOURISM MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 85.MEDICAL TOURISM MARKET REVENUE, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 86.NORTH AMERICA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 87.NORTH AMERICA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 88.NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 89.NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 90.U.S. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 91.U.S. MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 92.CANADA. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 93.CANADA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 94.MEXICO. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 95.MEXICO MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 96.EUROPE MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 97.EUROPE MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 98.EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 99.EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 100.GERMANY. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 101.GERMANY MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 102.FRANCE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 103.FRANCE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 104.UK TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 105.UK MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 106.ITALY TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 107.ITALY MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 108.SPAIN TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 109.SPAIN MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 110.REST OF EUROPE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 111.REST OF EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 112.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 113.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 114.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 115.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 116.INDIA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 117.INDIA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 118.CHINA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 119.CHINA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 120.INDONESIA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 121.INDONESIA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 122.SINGAPORE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 123.SINGAPORE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 124.MALAYSIA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 125.MALAYSIA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 126.THAILAND TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 127.THAILAND MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 128.SOUTH KOREA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 129.SOUTH KOREA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 130.TAIWAN TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 131.TAIWAN MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 132.REST OF ASIA-PACIFIC TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 133.REST OF ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 134.LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 135.LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 136.LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 137.LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 138.BRAZIL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 139.BRAZIL MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 140.VENEZUELA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 141.VENEZUELA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 142.COSTA RICA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 143.COSTA RICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 144.UAE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 145.UAE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 146.SOUTH AFRICA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 147.SOUTH AFRICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 148.REST OF LAMEA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 149.REST OF LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 150.APOLLO HOSPITALS: COMPANY SNAPSHOT
TABLE 151.APOLLO HOSPITALS: OPERATING SEGMENTS
TABLE 152.APOLLO HOSPITALS: PRODUCT PORTFOLIO
TABLE 153.FORTIS HEALTHCARE: COMPANY SNAPSHOT
TABLE 154.FORTIS HEALTHCARE: OPERATING SEGMENTS
TABLE 155.FORTIS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 156.AHI: COMPANY SNAPSHOT
TABLE 157.AHI: OPERATING SEGMENTS
TABLE 158.AHI: PRODUCT PORTFOLIO
TABLE 159.KPJ: COMPANY SNAPSHOT
TABLE 160.KPJ: OPERATING SEGMENTS
TABLE 161.KPJ: PRODUCT PORTFOLIO
TABLE 162.NTT MEDICAL CENTER: COMPANY SNAPSHOT
TABLE 163.NTT MEDICAL CENTER: OPERATING SEGMENTS
TABLE 164.SEOUL NATIONAL UNIVERSITY HOSPITAL: COMPANY SNAPSHOT
TABLE 165.SEOUL NATIONAL UNIVERSITY HOSPITAL: OPERATING SEGMENTS
TABLE 166.SEOUL NATIONAL UNIVERSITY HOSPITAL: PRODUCT PORTFOLIO
TABLE 167.UZ LEUVEN: COMPANY SNAPSHOT
TABLE 168.UZ LEUVEN: OPERATING SEGMENTS
TABLE 169.UZ LEUVEN: PRODUCT PORTFOLIO
TABLE 170.WOORIDUL SPINE HOSPITAL: COMPANY SNAPSHOT
TABLE 171.WOORIDUL SPINE HOSPITAL: PRODUCT PORTFOLIO
TABLE 172.ADITYA BIRLA MEMORIAL HOSPITAL: COMPANY SNAPSHOT
TABLE 173.ADITYA BIRLA MEMORIAL HOSPITAL: PRODUCT SEGMENTS
TABLE 174.ADITYA BIRLA MEMORIAL HOSPITAL: PRODUCT PORTFOLIO
TABLE 175.BARBADOS FERTILITY CENTRE: COMPANY SNAPSHOT
TABLE 176.BARBADOS FERTILITY CENTRE: OPERATING SEGMENTS
TABLE 177.BARBADOS FERTILITY CENTRE: PRODUCT PORTFOLIO
TABLE 178.PRINCE COURT MEDICAL CENTRE: COMPANY SNAPSHOT
TABLE 179.PRINCE COURT MEDICAL CENTRE: OPERATING SEGMENTS
TABLE 180.PRINCE COURT MEDICAL CENTRE: PRODUCT PORTFOLIO
TABLE 181.SAMITIVEJ HOSPITAL: COMPANY SNAPSHOT
TABLE 182.SAMITIVEJ HOSPITAL: OPERATING SEGMENTS
TABLE 183.SAMITIVEJ HOSPITAL: PRODUCT PORTFOLIO
TABLE 01.LIST OF MEDICAL TOURISM SPECIALTIES BY COUNTRIES
TABLE 02.GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2019–2027 ($MILLION)
TABLE 03.GLOBAL MEDICAL TOURISM MARKET, BY TREATMENT TYPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 04.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 05.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 06.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 07.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 08.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 09.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 10.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 11.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 12.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 13.MEDICAL TOURISM MARKET FOR DENTAL TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 14.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 15.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 16.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 17.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 18.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 19.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 20.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 21.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 22.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 23.MEDICAL TOURISM MARKET FOR COSMETIC TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 24.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 25.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 26.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 27.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 28.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 29.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 30.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 31.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 32.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 33.MEDICAL TOURISM MARKET FOR CARDIOVASCULAR TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 34.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 35.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 36.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 37.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 38.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 39.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 40.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 41.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 42.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 43.MEDICAL TOURISM MARKET FOR ORTHOPEDIC TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 44.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 45.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 46.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 47.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 48.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 49.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 50.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 51.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 52.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 53.MEDICAL TOURISM MARKET FOR NEUROLOGICAL TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 54.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 55.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 56.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 57.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 58.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 59.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 60.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 61.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 62.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 63.MEDICAL TOURISM MARKET FOR CANCER TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 64.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2019–2027 ($MILLION)
TABLE 65.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 66.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 67.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 68.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY EUROPE, 2019–2027 ($MILLION)
TABLE 69.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 70.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 71.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 72.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY LAMEA, 2019–2027 ($MILLION)
TABLE 73.MEDICAL TOURISM MARKET FOR FERTILITY TREATMENT, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 74.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY REGION, 2019–2027 ($MILLION)
TABLE 75.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 76.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY NORTH AMERICA, 2019–2027 ($MILLION)
TABLE 77.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY NORTH AMERICA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 78.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY EUROPE, 2019–2027 ($MILLION)
TABLE 79.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY EUROPE, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 80.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY ASIA-PACIFIC, 2019–2027 ($MILLION)
TABLE 81.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY ASIA-PACIFIC, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 82.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY LAMEA, 2019–2027 ($MILLION)
TABLE 83.MEDICAL TOURISM MARKET FOR OTHER TREATMENTS, BY LAMEA, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 84.MEDICAL TOURISM MARKET REVENUE, BY REGION, 2019–2027 ($MILLION)
TABLE 85.MEDICAL TOURISM MARKET REVENUE, BY REGION, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 86.NORTH AMERICA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 87.NORTH AMERICA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 88.NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 89.NORTH AMERICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 90.U.S. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 91.U.S. MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 92.CANADA. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 93.CANADA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 94.MEXICO. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 95.MEXICO MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 96.EUROPE MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 97.EUROPE MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 98.EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 99.EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 100.GERMANY. TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 101.GERMANY MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 102.FRANCE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 103.FRANCE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 104.UK TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 105.UK MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 106.ITALY TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 107.ITALY MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 108.SPAIN TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 109.SPAIN MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 110.REST OF EUROPE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 111.REST OF EUROPE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 112.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 113.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 114.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 115.ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 116.INDIA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 117.INDIA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 118.CHINA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 119.CHINA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 120.INDONESIA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 121.INDONESIA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 122.SINGAPORE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 123.SINGAPORE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 124.MALAYSIA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 125.MALAYSIA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 126.THAILAND TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 127.THAILAND MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 128.SOUTH KOREA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 129.SOUTH KOREA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 130.TAIWAN TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 131.TAIWAN MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 132.REST OF ASIA-PACIFIC TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 133.REST OF ASIA-PACIFIC MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 134.LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 ($MILLION)
TABLE 135.LAMEA MEDICAL TOURISM MARKET, BY COUNTRY, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 136.LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 137.LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 138.BRAZIL TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 139.BRAZIL MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 140.VENEZUELA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 141.VENEZUELA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 142.COSTA RICA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 143.COSTA RICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 144.UAE TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 145.UAE MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 146.SOUTH AFRICA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 147.SOUTH AFRICA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 148.REST OF LAMEA TOURISM MARKET, BY TREATMENT, 2019–2027 ($MILLION)
TABLE 149.REST OF LAMEA MEDICAL TOURISM MARKET, BY TREATMENT, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
TABLE 150.APOLLO HOSPITALS: COMPANY SNAPSHOT
TABLE 151.APOLLO HOSPITALS: OPERATING SEGMENTS
TABLE 152.APOLLO HOSPITALS: PRODUCT PORTFOLIO
TABLE 153.FORTIS HEALTHCARE: COMPANY SNAPSHOT
TABLE 154.FORTIS HEALTHCARE: OPERATING SEGMENTS
TABLE 155.FORTIS HEALTHCARE: PRODUCT PORTFOLIO
TABLE 156.AHI: COMPANY SNAPSHOT
TABLE 157.AHI: OPERATING SEGMENTS
TABLE 158.AHI: PRODUCT PORTFOLIO
TABLE 159.KPJ: COMPANY SNAPSHOT
TABLE 160.KPJ: OPERATING SEGMENTS
TABLE 161.KPJ: PRODUCT PORTFOLIO
TABLE 162.NTT MEDICAL CENTER: COMPANY SNAPSHOT
TABLE 163.NTT MEDICAL CENTER: OPERATING SEGMENTS
TABLE 164.SEOUL NATIONAL UNIVERSITY HOSPITAL: COMPANY SNAPSHOT
TABLE 165.SEOUL NATIONAL UNIVERSITY HOSPITAL: OPERATING SEGMENTS
TABLE 166.SEOUL NATIONAL UNIVERSITY HOSPITAL: PRODUCT PORTFOLIO
TABLE 167.UZ LEUVEN: COMPANY SNAPSHOT
TABLE 168.UZ LEUVEN: OPERATING SEGMENTS
TABLE 169.UZ LEUVEN: PRODUCT PORTFOLIO
TABLE 170.WOORIDUL SPINE HOSPITAL: COMPANY SNAPSHOT
TABLE 171.WOORIDUL SPINE HOSPITAL: PRODUCT PORTFOLIO
TABLE 172.ADITYA BIRLA MEMORIAL HOSPITAL: COMPANY SNAPSHOT
TABLE 173.ADITYA BIRLA MEMORIAL HOSPITAL: PRODUCT SEGMENTS
TABLE 174.ADITYA BIRLA MEMORIAL HOSPITAL: PRODUCT PORTFOLIO
TABLE 175.BARBADOS FERTILITY CENTRE: COMPANY SNAPSHOT
TABLE 176.BARBADOS FERTILITY CENTRE: OPERATING SEGMENTS
TABLE 177.BARBADOS FERTILITY CENTRE: PRODUCT PORTFOLIO
TABLE 178.PRINCE COURT MEDICAL CENTRE: COMPANY SNAPSHOT
TABLE 179.PRINCE COURT MEDICAL CENTRE: OPERATING SEGMENTS
TABLE 180.PRINCE COURT MEDICAL CENTRE: PRODUCT PORTFOLIO
TABLE 181.SAMITIVEJ HOSPITAL: COMPANY SNAPSHOT
TABLE 182.SAMITIVEJ HOSPITAL: OPERATING SEGMENTS
TABLE 183.SAMITIVEJ HOSPITAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL MEDICAL TOURISM MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP PLAYER POSITIONING, 2019
FIGURE 04.HIGH BARGANING POWER OF BUYERS
FIGURE 05.MODERATE BARGANING POWER OF SUPPLIERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.MODERATE THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE COMPETITIVE RIVALRY
FIGURE 09.IMPACT ANALYSES
FIGURE 10.U.S. MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 11.CANADA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 12.CANADA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 13.MEXICO MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 14.MEXICO MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 15.GERMANY MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 16.GERMANY MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 17.FRANCE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 18.FRANCE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 19.UK MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 20.UK MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 21.ITALY MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 22.ITALY MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 23.SPAIN MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 24.SPAIN MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 25.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 26.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 27.INDIA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 28.INDIA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 29.CHINA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 30.CHINA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 31.INDONESIA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 32.INDONESIA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 33.SINGAPORE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 34.SINGAPORE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 35.MALAYSIA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 36.MALAYSIA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 37.THAILAND MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 38.THAILAND MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 39.SOUTH KOREA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 40.SOUTH KOREA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 41.TAIWAN MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 42.TAIWAN MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 43.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 44.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 45.BRAZIL MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 46.BRAZIL MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 47.VENEZUELA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 48.VENEZUELA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 49.COSTA RICA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 50.COSTA RICA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 51.UAE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 52.UAE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 53.SOUTH AFRICA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 54.SOUTH AFRICA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 55.REST OF LAMEA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 56.REST OF LAMEA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 57.APOLLO HOSPITALS: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.APOLLO HOSPITALS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.FORTIS HEALTHCARE: REVENUE, 2017-2019 ($MILLION)
FIGURE 60.KPJ: NET SALES, 2017–2019 ($MILLION)
FIGURE 01.GLOBAL MEDICAL TOURISM MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP PLAYER POSITIONING, 2019
FIGURE 04.HIGH BARGANING POWER OF BUYERS
FIGURE 05.MODERATE BARGANING POWER OF SUPPLIERS
FIGURE 06.MODERATE THREAT OF SUBSTITUTION
FIGURE 07.MODERATE THREAT OF NEW ENTRANTS
FIGURE 08.MODERATE COMPETITIVE RIVALRY
FIGURE 09.IMPACT ANALYSES
FIGURE 10.U.S. MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 11.CANADA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 12.CANADA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 13.MEXICO MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 14.MEXICO MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 15.GERMANY MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 16.GERMANY MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 17.FRANCE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 18.FRANCE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 19.UK MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 20.UK MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 21.ITALY MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 22.ITALY MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 23.SPAIN MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 24.SPAIN MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 25.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 26.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 27.INDIA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 28.INDIA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 29.CHINA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 30.CHINA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 31.INDONESIA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 32.INDONESIA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 33.SINGAPORE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 34.SINGAPORE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 35.MALAYSIA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 36.MALAYSIA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 37.THAILAND MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 38.THAILAND MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 39.SOUTH KOREA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 40.SOUTH KOREA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 41.TAIWAN MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 42.TAIWAN MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 43.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 44.REST OF EUROPE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 45.BRAZIL MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 46.BRAZIL MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 47.VENEZUELA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 48.VENEZUELA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 49.COSTA RICA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 50.COSTA RICA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 51.UAE MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 52.UAE MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 53.SOUTH AFRICA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 54.SOUTH AFRICA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 55.REST OF LAMEA MEDICAL TOURISM MARKET, 2019–2027 ($MILLION)
FIGURE 56.REST OF LAMEA MEDICAL TOURISM MARKET, 2019–2027 (NUMBER OF PATIENTS IN THOUSANDS)
FIGURE 57.APOLLO HOSPITALS: NET SALES, 2017–2019 ($MILLION)
FIGURE 58.APOLLO HOSPITALS: REVENUE SHARE BY REGION, 2019 (%)
FIGURE 59.FORTIS HEALTHCARE: REVENUE, 2017-2019 ($MILLION)
FIGURE 60.KPJ: NET SALES, 2017–2019 ($MILLION)
